12/19
07:42 am
glue
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $11.00 price target on the stock, down previously from $14.00.
Medium
Report
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $11.00 price target on the stock, down previously from $14.00.
12/19
07:35 am
glue
Rating for GLUE
Medium
Report
Rating for GLUE
12/19
07:35 am
glue
Rating for GLUE
Medium
Report
Rating for GLUE
12/19
05:34 am
glue
Monte Rosa downgraded to Equal Weight from Overweight at Wells Fargo
Medium
Report
Monte Rosa downgraded to Equal Weight from Overweight at Wells Fargo
12/19
05:34 am
glue
Monte Rosa downgraded to Equal Weight from Overweight at Wells Fargo
Medium
Report
Monte Rosa downgraded to Equal Weight from Overweight at Wells Fargo